Literature DB >> 21119490

Delayed infection after a zygoma fracture fixation with absorbable plates.

Jang Hyun Lee1, Jung-Woo Chang, Matthew Seung Suk Choi, Hee Chang Ahn.   

Abstract

A 48-year-old man who had received a bioresorbable plate fixation for a zygomatic bone fracture 13 months earlier visited our clinic complaining of sudden facial swelling. The facial computed tomographic scan showed the soft tissue swelling without any bony abnormality, and the symptoms did not improve after 1 week of antibacterial therapy. The patient had a diagnosis of a late infection caused by unresorbed plates, and exploratory surgery was performed. Partially resorbed plates and screws were seen, and we removed the remnants of such completely. The symptoms were relieved after the operation, and there was no recurrence during 8 months of follow-up.

Entities:  

Mesh:

Year:  2010        PMID: 21119490     DOI: 10.1097/SCS.0b013e3181f5387c

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  4 in total

1.  Delayed Methicillin-Resistant Staphylococcus aureus Infection on a Mandibular Angle Fracture with Absorbable Plates.

Authors:  Han Moi Choi; Soon Heum Kim; Cheol Keun Kim; Hyun Gon Choi; Dong Hyeok Shin; Ki Il Uhm; Dongin Jo
Journal:  Arch Plast Surg       Date:  2015-03-16

Review 2.  Absorbable Plate-Related Infection after Facial Bone Fracture Reduction.

Authors:  Seung Hyup Choi; Jang Hyun Lee
Journal:  Arch Craniofac Surg       Date:  2016-03-21

3.  Delayed-Onset Methicillin-Resistant Staphylococcus aureus Infection at 18 Months after Absorbable Plate Fixation for Zygomaticomaxillary Complex Fracture.

Authors:  Hyun Rok Lee; Hea Kyeong Shin; Dong Lark Lee; Gyu Yong Jung
Journal:  Arch Craniofac Surg       Date:  2016-12-23

4.  Long-term outcomes of metacarpal fractures surgically treated using bioabsorbable plates: a retrospective study.

Authors:  Kenji Kosugi; Yukichi Zenke; Takafumi Tajima; Yoshiaki Yamanaka; Kunitaka Menuki; Akinori Sakai
Journal:  BMC Musculoskelet Disord       Date:  2020-12-07       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.